Springboard Enterprises: Applications Open for Health Innovation Hub
The Health Innovation Hub is Springboard’s program for women-led companies seeking growth funding and expert connections to develop solutions in pharma, including new drugs, diagnostics, pharma technologies, and drug-delivery devices.
Exact Imaging Secures CDN $21.5 Million to Support Commercialization of Its Exactvu™ Micro-Ultrasound
TORONTO, CANADA -- (January 5, 2017) Exact Imaging (www.exactimaging.com), the world’s leader in high resolution micro-ultrasound systems enabling real-time imaging and biopsy guidance for the prostate, announced it has secured CDN $21.5 million in a Series C investment to commercialize its ExactVu™ micro-ultrasound system.
Versant Ventures Closes 6th Healthcare Fund
Versant Ventures has announced the close of its newest fund, Versant Venture Capital VI, at its hard cap of CAD538 million (USD400 million). Versant will use its diversified global investment strategy to find, form and fund innovative healthcare companies with an emphasis on novel therapeutics.
OxiLight Inc Releases New Video
OBIO Pre-CAAP company, OxiLight Inc, has released a new video about their innovative wound imaging system for diabetic foot ulcers and peripheral vascular disease and how their technology can save lives and limbs
The ChipCare Team Grows
Former OBIO CAAP company, ChipCare Corporation, a Toronto-based start-up company creating a point-of-care platform that will bring lifesaving diagnostics to millions without access, has expanded its team
Intronix Technologies Upgrades
Former OBIO CAAP company, Intronix Technologies, have upgraded their Myoguide Stimulator capability.
Eve Medical Featured in MIT Technology Review
Eve Medical is as an up and coming technology trend to watch in women's health.
Versant Ventures Announces Milestone with Recent Northern Biologics and BlueRock Therapeutics Deals
TORONTO & MONTREAL & VANCOUVER, British Columbia December 19, 2016 -Versant Ventures today announced that Toronto-based portfolio company Northern Biologics Inc. has executed a transformational deal that expands its pipeline and financial resources, bringing commitments to Versant’s Canadian biotech portfolio to over CAD$500 million.
MDCC Website Relaunched
On December 15 MDCC re-launched their website!
Click here to check out the new website
Bayer and Versant Ventures Join Forces to Launch Stem Cell Therapy Company BlueRock Therapeutics with USD 225 Million Series A Financing
LEVERKUSEN, Germany and BOSTON and NEW YORK and TORONTO and KYOTO, Japan, Dec. 12, 2016 - Bayer AG and Versant Ventures today announced the launch of BlueRock Therapeutics, a next-generation regenerative medicine company that plans to develop best-in-class induced pluripotent stem cell (iPSC) therapies to cure a range of diseases using an industry-leading platform. BlueRock Therapeutics will be led by a world-class team and has assembled its platform through a series of strategic partnerships with academia and industry.
OBIO Announces New Public Relations & Communications Services Member Benefit
TORONTO, Dec. 7, 2016 - HOWE&WYE is proud to announce its new partnership with OBIO®. As a part of OBIO's new member benefit, HOWE&WYE will provide strategic public relations and communications services to OBIO's broad membership of world-class start-ups and bioscience companies. OBIO members will benefit from special access to top-tier agency support with optimized pricing to strengthen PR and marketing to fulfill strategic business outcomes for awareness, investment and commercialization.
OBIO® Launches the Health 2 Business Bridge Program™ H2BB™ Improving Access to Business Trained Talent in Ontario’s Health Science Industry
CAAP Company: GaitTronics SoloWalk Featured in Ottawa Hospital Journal
GaitTronics SoloWalk has been tested with cerebral palsy patients at the Ottawa Children’s Treatment Centre. But geriatric patients have different needs, so they’re working with Dr. Huang and other GMU staff members to test the walker at TOH.
CAAP Company: BrainFx SCREEN Self Diagnostic Now Live
The BrainFx SCREEN, a 15 minute brain health check-up that answers the question, ‘Do I need more tests?’ Try it out today!
PreCAAP Company: Greenspace Mental Health Present Demo Video on Their Technolnogy
Greenspace Mental Health has created a new demo video on how therapists now automatically have their own test patient.
Pre-CAAP Company: Sojourn Labs Awarded $50,000 to Advance Their Technology in Support of a Lower-Carbon Future for Canada
Shell Canada's Quest Climate Grant has awarded three Canadian clean technology innovations with $50,000 per project to recognize their efforts in helping to combat climate change. The recipients were chosen based on their unique business and/or product concept and their commitment to working on promising climate change innovations.
OBIO Presents at Sunnybrook Medventions Innovation Day
OBIO was invited to speak at the Sunnybrook Medventions Innovation Day on Monday November 28th, presented by the Schulich Heart Program.
CAAP Company: ChipCare Retains Biotech Alliances International to Lead Series B Capital Raise
ChipCare, a Toronto-based start-up diagnostic company, announced today that San Francisco-based life sciences investment bank Biotech Alliances International will serve as the lead investment banker for its $18.8 million Series B capital raise, $2.8 million of which has already been secured.
Call for Innovations: Canadian Centre for Aging and Brain Health Innovation (CC-ABHI)
CAAP Company: Medella Health featured in JDRF
Medella Health featured in JDRF. JDRF is the leading global organization focused on type 1 diabetes (T1D) research.